- Home
- PTGX vs CUBI Comparison
PTGX vs CUBI Comparison
Compare PTGX & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTGX | CUBI |
|---|---|---|
| Founded | 2006 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 2.5B |
| IPO Year | 2016 | 2012 |
Fundamental Metrics
Financial Performance| Metric | PTGX | CUBI |
|---|---|---|
| Price | $89.33 | $74.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $88.33 | $84.14 |
| AVG Volume (30 Days) | ★ 966.5K | 306.4K |
| Earning Date | 11-06-2025 | 01-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.72 | ★ 4.96 |
| Revenue | $209,217,000.00 | ★ $651,983,000.00 |
| Revenue This Year | N/A | $16.77 |
| Revenue Next Year | $296.47 | $6.91 |
| P/E Ratio | $127.10 | ★ $14.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $33.70 | $40.75 |
| 52 Week High | $96.54 | $74.57 |
Technical Indicators
Market Signals| Indicator | PTGX | CUBI |
|---|---|---|
| Relative Strength Index (RSI) | 55.04 | 69.37 |
| Support Level | $88.30 | $69.00 |
| Resistance Level | $96.54 | $74.57 |
| Average True Range (ATR) | 3.16 | 2.00 |
| MACD | -0.19 | 0.39 |
| Stochastic Oscillator | 44.59 | 96.04 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.